Nano-X Imaging

Nano-X Imaging Ltd. is engaged in the development of medical imaging systems. Its product Nanox System consists of hardware Nanox.ARC and software Nanox.CLOUD that provides image repository, radiologist matching, online and offline diagnostics review and annotation, connectivity to diagnostic assistive artificial intelligence systems, billing, and reporting. The firm operates through the following segments: Nanox.Arc, AI Solutions, and Radiology Services. The company was founded by Ran Poliakine and Hitoshi Masuya in 2011 and is headquartered in Neve Ilan, Israel.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Nano-X Imaging reports improved Q1 performance and expands global presence

Nano-X Imaging Ltd. reported improved financial performance, highlighted by the FDA clearance for Nanox.ARC system and strategic partnerships. However, challenges in scaling operations and deployment in key regions persist. The company is well-positioned to capitalize on opportunities through expansion and commercialization efforts.

Nano-X Imaging Reports Improved Q2 Performance and Explores Growth Opportunities

Nano-X Imaging reported improved financial performance with a reduced net loss and successful fundraising. The company faces challenges in achieving profitability and expanding its commercialization efforts. However, opportunities lie in upcoming events, FDA clearance, and strategic partnerships for potential growth.

Nanox intensifies U.S. market efforts amidst mixed Q3 performance

Nanox reported mixed financial performance with a focus on U.S. market expansion and regulatory progress. While facing financial challenges, the company's strategic agreements and strong cash position offer potential growth opportunities. The upcoming Investor Day signals optimism for the future and an opportunity to engage with investors.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Nano-X Imaging Ltd. is engaged in the development of medical imaging systems. Its product Nanox System consists of hardware Nanox.ARC and software Nanox.CLOUD that provides image repository, radiologist matching, online and offline diagnostics review and annotation, connectivity to diagnostic assistive artificial intelligence systems, billing, and reporting. The firm operates through the following segments: Nanox.Arc, AI Solutions, and Radiology Services. The company was founded by Ran Poliakine and Hitoshi Masuya in 2011 and is headquartered in Petach Tikva, Israel.

Amarin Corporation Plc

Invitae

All three companies have enjoyed major growth catalysts since the start of 2021.

3 Top Healthcare Stocks to Buy in April

Riot Blockchain

They may not be the most obvious picks, but they could be quite rewarding down the line.

3 Unusual Growth Stocks to Buy Now

The FDA recently cleared its digital X-ray concept; here's what has to happen next to generate shareholder value.

3 Things Nano-X Needs to Do to Make You Rich

NEVE ILAN, Israel, April 06, 2021 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (www.nanox.vision) (“Nanox” or the “Company”), the innovative medical imaging technology company democratizing healthcare, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2020 with the U.S. Securities and Exchange Commission (“SEC”) on April 6, 2021. The annual report on Form 20-F, which contains the Company's audited consolidated financial statements, can be accessed on the SEC's website at www.sec.gov and on the Company's website at www.nanox.vision under “Financials” in the Investors section.

NANO-X IMAGING LTD Files 2020 Annual Report on Form 20-F

The Israeli medical equipment company came out with good news on Friday regarding its single-source digital X-ray imaging system, and the market reacted positively.

Why Is Nano-X Imaging Stock Soaring?

Canopy Growth

Etsy

Marathon Digital Holdings

Nano-X Imaging, Etsy, Mara Digital Holdings and Canopy Growth were our top stock trades for Tuesday. That said, let's look at the charts.

4 Top Stock Trades for Tuesday: NNOX, ETSY, MARA, CGC

JetBlue Airways

Most Nasdaq stocks were sharply higher Monday.

Nano-X Sends Nasdaq Soaring; JetBlue Nears Multi-Year Highs

The company will start shipping its X-ray machines to hospitals in the fourth quarter of 2021.

Nano-X Imaging Receives FDA Clearance for X-Ray Device

The company won FDA clearance for its single-source digital X-ray technology.

Why Nanox Stock Is Skyrocketing Today

NNOX stock is soaring on Monday after Nano-X announced it had reached another regulatory milestone with the FDA. The post NNOX Stock: Nano-X Rockets Higher on Big FDA Milestone appeared first on InvestorPlace.

NNOX Stock: Nano-X Rockets Higher on Big FDA Milestone

Chembio Diagnostics

Chembio Diagnostics Inc (NASDAQ: CEMI) shares are trading higher by 41% in Monday's pre-market session after the company announced the commercial launch of a test to differentiate between COVID-19 and the Flu. Chembio develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases.

Why NNOX Stock And CEMI Stock Are Skyrocketing Today

The stock price of Nano-X Imaging Ltd (NASDAQ: NNOX) increased by over 50% pre-market. This is why it happened.

Nano-X Imaging Stock Price Increased Over 50% Pre-Market: Why It Happened

Nano-X Imaging Ltd (NASDAQ: NNOX) stock is seeing high social media interest on Monday. The company's shares last closed 0.29% lower at $41.33 on Thursday.

What's Happening With Nano-X Imaging Stock?

Tesla

With the NASDAQ and growth sectors rebounding nicely last week, let's take a look at three stocks with some major catalysts heading into April, the first month of the second quarter.

3 Stocks for Early April

NEVE ILAN, Israel, April 02, 2021 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, announced today that its single-source Nanox.ARC digital x-ray technology has received 510(k) clearance from the US Food and Drug Administration (the “FDA”).

Nanox Announces FDA Clearance of 510(k) for Single Source Nanox.ARC Digital X-Ray

Investors need to pay close attention to Nano-X Imaging (NNOX) stock based on the movements in the options market lately.

Are Options Traders Betting on a Big Move in Nano-X Imaging (NNOX) Stock?

Fluidigm

Guardant Health Inc

Innovation is risky, and these companies are all in.

3 Extraordinary Diagnostics Stocks for 2021

Apple

Boeing

Visa

Boeing, Apple, Nano-X Imaging and Visa were our top stock trades for Monday. Let's have a look at the charts for next week.

4 Top Stock Trades for Monday: BA, AAPL, NNOX, V

NEVE ILAN, Israel, March 15, 2021 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announces that Nanox's Founder and Chief Executive Officer Ran Poliakine will deliver a company presentation and the leadership team will host investor 1x1 meetings during the Oppenheimer 31st Annual Virtual Healthcare Conference, which is being held from March 16 through March 18.

Nanox to Participate in the Virtual 31st Annual Oppenheimer Healthcare Conference

This healthcare disrupter is about to receive FDA clearance to start distributing its new X-ray device.

Is Nano-X a Buy?

On one hand, NNOX stock is supported by a groundbreaking medical innovations. But on the other, economic problems present severe headwinds.

Nano-X Imaging Has the Right Science at the Wrong Time

The X-ray disrupter is almost 50% off its highs.

Nano-X Imaging: Buy the Dip?

Nano-X Imaging's (NNOX) CEO Rand Poliakine on Q4 2020 Results - Earnings Call Transcript

Jumia

Boeing, TJX Companies, Jumia and Nano-X Imaging were our top stock trades from Wednesday. That said, let's look at the charts now.

4 Top Stock Trades for Thursday: BA, TJX, JMIA, NNOX

Management to host conference call and webcast at 8:30 AM ET Management to host conference call and webcast at 8:30 AM ET

News for Nano-X Imaging Stock (NNOX)